SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000918066-04-000083
Filing Date
2004-10-05
Accepted
2004-10-05 15:12:11
Documents
1
Period of Report
2004-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 10511
  Complete submission text file 0000918066-04-000083.txt   12348
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GUILFORD PHARMACEUTICALS INC 6611 TIBUTARY ST BALTIMORE MD 21224
Business Address 6611 TRIBUTARY STREET C/O GUILFORD PHARMACEUTICALS INC BALTIMORE MD 21224 4106316300
NORDMANN RONALD M (Reporting) CIK: 0001206371 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23736 | Film No.: 041065803